These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 12601453

  • 1. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I, Nitzsche EU, Mix M, Schindler T, Hentschel M, Högerle S, Moser E.
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [Abstract] [Full Text] [Related]

  • 2. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD, deKemp RA, Ruddy TD, Williams K, Beanlands RS.
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [Abstract] [Full Text] [Related]

  • 3. Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients.
    Hasegawa S, Kusuoka H, Uehara T, Yamaguchi H, Hori M, Nishimura T.
    Ann Nucl Med; 1998 Dec; 12(6):363-8. PubMed ID: 9972374
    [Abstract] [Full Text] [Related]

  • 4. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ, Visser FC, Raymakers PG, Van Lingen A, Cornel JH, Huitink JM, Elhendy A, Heine RJ, Visser CA.
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [Abstract] [Full Text] [Related]

  • 5. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
    Knuuti MJ, Nuutila P, Ruotsalainen U, Teräs M, Saraste M, Härkönen R, Ahonen A, Wegelius U, Haapanen A, Bergman J.
    J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
    Schröder O, Hör G, Hertel A, Baum RP.
    Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
    [Abstract] [Full Text] [Related]

  • 11. [Glucose metabolism in ischemic myocardium: quantitative imaging using positron emission tomography].
    Takahashi A, Ono Y, Sudo M, Araki K, Shishido F, Uemura K, Kadowaki K, Kumagai T.
    J Cardiogr; 1986 Jun; 16(2):291-9. PubMed ID: 3495606
    [Abstract] [Full Text] [Related]

  • 12. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
    Ng CK, Soufer R, McNulty PH.
    J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    Thorn SL, deKemp RA, Dumouchel T, Klein R, Renaud JM, Wells RG, Gollob MH, Beanlands RS, DaSilva JN.
    J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
    [Abstract] [Full Text] [Related]

  • 15. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
    Bax JJ, Visser FC, Poldermans D, van Lingen A, Elhendy A, Boersma E, Visser CA.
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
    Martin WH, Jones RC, Delbeke D, Sandler MP.
    Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
    Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK.
    J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the myocardial FDG-PET image quality with the use of maximal Standardized Uptake Value myocardial to background index. Application of the results in regard to semiquantitative assessment of myocardial viability with cardiac dedicated softwar.
    Kobylecka M, Mazurek T, Fronczewska-Wieniawska K, Fojt A, Słowikowska A, Mączewska J, Chojnowski M, Bajera A, Płazińska MT, Królicki L.
    Nucl Med Rev Cent East Eur; 2017 Jan; 20(2):69-75. PubMed ID: 28555447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.